MedTrace Logo

Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer

NCT04191460 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-02-26

No results posted yet for this study

Summary

This is a two-staged clinical trial to investigate the feasibility of intraoperative Fluorescence Imaging (FLI) to adequately assess tumor margins in patients with oral cancer using cRGD-ZW800-1.

Conditions

  • Squamous Cell Carcinoma of the Head and Neck
  • Oral Cancer
  • Squamous Cell Carcinoma of the Oral Cavity

Interventions

DRUG

cRGD-ZW800-1.

Injection of cRGD-ZW800-1 within 48 hours before imaging/surgery

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-12
Primary Completion
2025-05-01
Completion
2025-07-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04191460 on ClinicalTrials.gov